Dr. Hans Keirstead is an internationally recognized stem cell expert and entrepreneur in regenerative medicine. He has pioneered therapies for cancer, immune disorders, motor neuron diseases, spinal cord injury, retinal diseases, immune disorders, age-related immune decline, and has created a novel multi-pathogen vaccine kit. Each of Dr. Keirstead’s three biotechnology firms was sold to major pharmaceutical companies for 2.5x-9.5x returns to investors after return of investment capital. He holds board positions in several leading biotechs including AIVITA Biomedical, Immunis Inc., and the global Human Immune Project. His international media recognition includes being listed as one of Discover Magazine’s top 100 scientists and being highlighted by Newsweek, WIRED, The New York Times, TIME Magazine, Science, 60 Minutes, PBS, and more. Some of Dr. Keirstead’s notable awards include the “Top 20 Canadians” Award by the Consul General of Canada, the NIH Solowey award for noted national researcher of the year, recognition as a world thought leader at the Seven Wonderer's event by Beakerhead, and the Cameron Award for the best Ph.D. in the country. Dr. Keirstead received his Ph.D. in neuroscience from the University of British Columbia, Canada, and pursued his postdoctoral research at the University of Cambridge, England.